麻豆传媒

Related Sections

• Appellate
• Competition
• 麻豆传媒
• Life Sciences
• Technology

麻豆传媒 Firms

• Finnegan
• Jones Day
• Kramer Levin
• Steptoe LLP

Companies

• AbbVie Inc.
• Alexion Pharmaceuticals Inc.
• Amgen Inc.
• Arthrex Inc.
• Biogen Inc.
• Boehringer Ingelheim Vetmedica Inc.
• Coherus BioSciences Inc.
• Eli Lilly & Co.
• F. Hoffmann-La Roche Ltd.
• Fresenius Kabi AG
• Genentech Inc.
• Genzyme Corp.
• GSK PLC
• Hospira Inc.
• Kashiv BioSciences LLC
• Lupin Ltd.
• Merck & Co. Inc.
• New York University
• Pfenex Inc.
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Samsung Electronics Co. Ltd.
• Sandoz International GmbH
• Sanofi
• Smith & Nephew plc
• Teva Pharmaceutical Industries Ltd.
• uniQure NV
• Viatris Inc.

Government Agencies

• Patent Trial and Appeal Board
• U.S. Court of Appeals for the Federal Circuit

Patents

• 6,407,213 - Method for making humanized antibodies
• 8,530,171 - High level expression of recombinant toxin proteins
• 8,940,878 - Capture purification processes for proteins expressed in a non-mammalian system
• 9,090,689 - Use of TNF.alpha. inhibitor for treatment of psoriasis
• 9,067,992 - Use of TNF.alpha. inhibitor for treatment of psoriatic arthritis
• 8,679,487 - Anti-interleukin-4 receptor antibodies
• 9,982,248 - Factor IX polypeptide mutant, its uses and method for its production
• 10,465,180 - Factor IX polypeptide mutant, its uses and method for its production
• 8,562,999 - Formulations which stabilize and inhibit precipitation of immunogenic compositions
• 9,643,997 - Capture purification processes for proteins expressed in a non-mammalian system
• 8,586,045 - Methods of using anti-CGRP antagonist antibodies
• 8,597,649 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
• 9,266,951 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
• 9,340,614 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
• 9,346,881 - Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
• 8,821,873 - Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
• 9,884,907 - Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
• 9,884,908 - Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
• 9,856,287 - Refolding proteins using a chemically controlled redox state
• 8,753,645 - Conjugation process of bacterial polysaccharides to carrier proteins
• 9,265,839 - Conjugation process of bacterial polysaccharides to carrier proteins
• 9,890,210 - Antagonist antibodies directed against calcitonin gene-related peptide
• 9,890,211 - Antagonist antibodies directed against calcitonin gene-related peptide
• 9,492,559 - Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
• 9,505,827 - Animal models and therapeutic molecules
• 9,434,782 - Animal models and therapeutic molecules
• 9,447,177 - Transgenic mouse homozygous for chimeric IgH locus
• 10,064,398 - Animal models and therapeutic molecules
• 9,249,405 - Factor IX polypeptide mutant, its uses and a method for its production
• 10,165,763 - Animal models and therapeutic molecules
• 9,732,149 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
• 9,725,504 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
• 9,718,880 - Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
• 9,220,631 - Syringe
• 9,399,060 - Multivalent pneumococcal polysaccharide-protein conjugate composition
• 8,895,024 - Multivalent pneumococcal polysaccharide-protein conjugate composition
• 9,422,345 - Expression system